Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer

Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients

(2020) Daan P. Hurkmans et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab

(2019) Andre Kunert et al.   Journal for ImmunoTherapy of Cancer

Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients

(2018) Sander Bins et al.   BRITISH JOURNAL OF CANCER

Meta-analysis of the association of IL2RA polymorphisms rs2104286 and rs12722489 with multiple sclerosis risk

(2018) Xiao-Xiong Wang et al.   IMMUNOLOGICAL INVESTIGATIONS

T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition

(2017) Enfu Hui et al.   SCIENCE

Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

(2017) Diego Chowell et al.   SCIENCE

Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent

(2017) Alice O. Kamphorst et al.   SCIENCE

Expression of intra- and extracellular granzymes in patients with typhoid fever

(2017) Hanna K. de Jong et al.   PLoS Neglected Tropical Diseases

Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants

(2016) Ying Jin et al.   NATURE GENETICS

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

(2016) Jesse M. Zaretsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association between interferon-γ +874 T/A polymorphism and susceptibility to autoimmune diseases: a meta-analysis

(2015) Y H Lee et al.   LUPUS

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

(2015) Julie Brahmer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

(2015) Hossein Borghaei et al.   NEW ENGLAND JOURNAL OF MEDICINE

The associations between PD-1, CTLA-4 gene polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis and systemic review

(2015) Si Chen et al.   RHEUMATOLOGY INTERNATIONAL

Association of ZAP70 and PTPN6, but Not BANK1 or CLEC2D, with Inflammatory Bowel Disease in the Tunisian Population

(2013) Dorra Bouzid et al.   Genetic Testing and Molecular Biomarkers

Risk of Generalized Vitiligo Is Associated with the Common 55R-94A-247H Variant Haplotype of GZMB (Encoding Granzyme B)

(2013) Tracey M. Ferrara et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

A Comprehensive Analysis of Shared Loci between Systemic Lupus Erythematosus (SLE) and Sixteen Autoimmune Diseases Reveals Limited Genetic Overlap

(2011) Paula S. Ramos et al.   PLoS Genetics

Association of IL2RA and IL2RB with rheumatoid arthritis: a replication study in a Dutch population

(2009) F A S Kurreeman et al.   ANNALS OF THE RHEUMATIC DISEASES

Interferon-gamma gene polymorphisms associated with susceptibility to systemic lupus erythematosus

(2009) K. Kim et al.   ANNALS OF THE RHEUMATIC DISEASES

Polymorphisms of PTPN11 Coding SHP-2 as Biomarkers for Ulcerative Colitis Susceptibility in the Japanese Population

(2009) Yukiko Narumi et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population

(2009) Xiang Liu et al.   RHEUMATOLOGY INTERNATIONAL

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER